IGF1 and type 2 diabetes mellitus: We hypothesized that, as seen in type 2 diabetes and insulin resistance, amelioration of what we interpreted as development of IGF-I resistance in aged orexin neurons, could be achieved by administration of IGF-I sensitizers.